Please assess the completion status of the following clinical trial:

Trial Title: Effect of Progesterone on Testosterone Concentrations and Breast Development in Transwomen

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Transwomen, currently on treatment with estradiol therapy for at least 6 months (as their standard of care gender affirming therapy)~* Has achieved serum estradiol \>100 pg/ml at least once, based on clinical labs in past.~Exclusion Criteria:~1. Treatment with progesterone in the last 2 months~2. HIV~3. Planning to go for breast enhancement or gender reassignment surgery in the next 6 months~4. Known history of peanut allergy (because the study drug contains peanut oil)~5. Active deep vein thrombosis, pulmonary embolism or history of these conditions~6. Active arterial thromboembolic disease or history of these conditions~7. Active cardiovascular disorders or history of these conditions (e.g. myocardial infarction, uncontrolled hypertension \>150/90 mmHg)~8. Known, suspected, or history of breast cancer~9. Known liver dysfunction or disease~10. Known or history of gallbladder disease. This does not apply to subjects who have undergone cholecystectomy~11. Known or history of hypertriglyceridemia (\>400 mg/dl)

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- progesterone (Type: ACTIVE_COMPARATOR): subjects on active drug (progesterone)
- placebo (Type: PLACEBO_COMPARATOR): subjects on placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).